The Dermashine Pro, now available through Novus Medical, introduces a precision skin infusion platform designed to support modern injectable treatment workflows.

The demand for injectable skin treatments continues to grow rapidly across aesthetic clinics. Treatments designed to improve skin hydration, texture, and overall skin quality are becoming an increasingly important part of many clinic treatment menus.

As these treatments become more popular, clinics are also looking for technologies that allow them to deliver injectable skin therapies more efficiently, more consistently, and with greater precision.

Already widely used across South Korea one of the world’s most advanced aesthetic medicine markets, Dermashine technology is used in approximately one in two aesthetic clinics.

What is Dermashine Pro?

Dermashine Pro is a precision-controlled injectable delivery platform designed to support structured skin treatment programmes.

The system allows practitioners to deliver injectable skin treatments with controlled depth, consistent dosing and uniform distribution across treatment areas.

Unlike manual injection techniques, which depend heavily on practitioner technique, Dermashine Pro introduces a protocol-driven delivery approach, helping clinics standardise injectable treatment workflows.

The platform can be used as a delivery system for a range of injectable skin treatments including:

• skin boosters
• polynucleotides
• regenerative injectable therapies
• hyaluronic acid skin treatments
• biologic skin programmes where appropriate

Why clinics are moving towards precision delivery systems

Traditional manual injection techniques can deliver good results, but they often rely heavily on practitioner technique to determine:

• injection depth
• dosing consistency
• spacing between injections
• treatment speed

This variability can make it difficult to maintain consistent treatment protocols across practitioners.

Dermashine Pro introduces a precision-controlled delivery platform that helps support more standardised treatment delivery.

Key technology features include:

Vacuum-assisted stabilisation
Supports consistent contact between the delivery head and the skin surface.

Controlled depth settings
Helps maintain consistent injection depth across practitioners.

Automated dosing delivery
Supports predictable product distribution across treatment areas.

Multi-needle delivery system
Allows efficient coverage of larger treatment zones.

Up to 80% faster treatment delivery

One of the major advantages of automated precision delivery platforms is treatment efficiency.

Dermashine Pro can deliver injectable skin treatments up to 80% faster compared with conventional manual injection techniques, depending on practitioner protocol and treatment indication.

For clinics offering skin booster or regenerative injectable treatments, this can significantly improve operational efficiency.

Potential benefits include:

• increased patient throughput
• improved practitioner time efficiency
• consistent treatment delivery across larger areas
• enhanced patient comfort through controlled delivery

As injectable skin treatments continue to grow in popularity, many clinics are looking for technologies that allow them to scale treatment programmes without increasing treatment time.

Proven technology widely used in South Korea

South Korea is widely recognised as one of the most advanced aesthetic medicine markets in the world.

Dermashine technology has achieved widespread adoption across Korean aesthetic clinics and is currently used in approximately half of all clinics offering injectable skin treatments.

This level of adoption reflects the growing demand for precision delivery platforms that support structured treatment protocols.

The introduction of Dermashine Pro to the UK provides clinics with access to technology already widely used in a highly developed aesthetic market.

Treatment applications

Dermashine Pro can be used as a delivery platform across a variety of injectable skin treatment protocols.

Typical applications include:

Skin quality improvement

• skin hydration
• skin texture improvement
• pore refinement

Regenerative injectable treatments

• polynucleotide treatments
• regenerative skin therapies

Injectable skin programmes

• hyaluronic acid skin boosters
• injectable skin rejuvenation treatments

Treatment areas

Dermashine Pro can be used across a range of treatment areas including:

• face
• periorbital region
• neck
• décolletage
• hands
• scalp (protocol dependent)

Supporting clinics implementing injectable skin programmes

For clinics introducing or expanding injectable skin treatments, the integration of a precision delivery platform can help support structured treatment protocols and scalable treatment programmes.

Clinics working with Novus Medical receive support including:

• device onboarding and setup
• practitioner training
• protocol guidance
• implementation support

This allows clinics to introduce Dermashine Pro as part of a structured treatment offering.

Dermashine Pro now available in the UK

Dermashine Pro is now available through Novus Medical, supporting aesthetic clinics looking to expand their injectable skin treatment offering with a precision delivery platform.

With patient demand for skin quality treatments, regenerative injectables, and skin booster therapies continuing to grow, technologies that support efficient, consistent treatment delivery are becoming an increasingly valuable part of modern aesthetic practice.

Clinics interested in learning more about Dermashine Pro can explore how precision delivery platforms may support their treatment offering.